How to improve the efficacy of endoscopic intravariceal plus paravariceal injection lauromacrogol sclerotherapy for treatment of esophageal varices

doi:10.3969/j.issn.1006-7795.2016.05.008

Abstract

Abstract: Objective To investigate the efficacy of Endoscopic intravariceal plus paravariceal injection lauromacrogol sclerotherapy for treatment of esophageal variceal and the methods to improve the efficacy. Methods We retrospectively analyzed the 260 patients who underwent endoscopic intravariceal plus paravariceal injection lauromacrogol sclerotherapy. Then we observed the efficacy for emergency hemostasis and remission and complications of the endoscopic injection sclerotherapy (EIS). Results ①The efficacy of the therapy was associated with the times of therapies. The efficacy of therapy for every time was very significant (P≤0.001). The rate of esophageal varices remission was 96.55% (28/29) and that of recovery to G1 or disappeared was 82.76% (24/29) after four times of therapies. ②Success rate of emergency endoscopic hemostatis was 94.20% (65/69).③Thirteen patients with early rebleeding and 27 patients with late rebleeding, 4 patients had complications including 2 patients with esophageal mucosal erosion and bleeding and 2 patients with esophageal stenosis, they received treatments and recovered. Conclusion Endoscopic intravariceal plus paravariceal injection lauromacrogol sclerotherapy for treatment of esophageal varices was effective and safe, and the efficacy can be improved with more times of treatments and short intervals.

Key words: esophageal varices, lauromacrogol, endoscopic injection sclerotherapy, intravariceal and paravariceal

CLC Number:

R571⁺.3

Xu Changqin, Liu Hui, Xu Hongwei. How to improve the efficacy of endoscopic intravariceal plus paravariceal injection lauromacrogol sclerotherapy for treatment of esophageal varices[J]. Journal of Capital Medical University, 2016, 37(5): 597-601.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2016.05.008

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2016/V37/I5/597

References

[1] Jaime B C, Annaro D A, Guan C G. Portal hypertension and nonsurgicai management. Sciff's disease of the liver[M]. 10th ed. Philadelphia:Lippincott Williams & Wilkins, 2007:420-485.
[2] 刘运祥, 黄留业. 实用消化内镜治疗学[M]. 2版. 北京:人民卫生出版社, 2008:107.
[3] 中华医学会消化病学分会, 中华医学会肝病学分会, 中华医学会内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治共识[J]. 中华肝脏病杂志, 2008, 16(8):564-570.
[4] 中华外科学分会门静脉高压症学组. 肝硬化门静脉高压症食管胃底静脉曲张破裂出血的诊治共识(2015版)[J]. 中华普通外科杂志, 2016, 31(2):167-170.
[5] 管建国, 徐玉龙, 王焕兵, 等. 肝硬化门静脉高压症上消化道出血微创治疗进展[J]. 中外医学研究, 2011, 9(22):147-148.
[6] 程留芳, 李长政. 全国多中心食管胃静脉曲张出血调查[J]. 临床肝脏病学, 2012, 28(6):462-464.
[7] Pereira S P, Wilkinson M L. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices:influence on gastropathy, gastric varices and variceal recurrence[J]. Gastrointest Endosc, 1997, 46(4):384-385.
[8] Miyaaki H, Ichikawa T, Taura N, et al. Endoscopic management of esophagogastric varices in Japan[J]. Ann Transl Med, 2014,2(5):42.
[9] Poza Cordon J, Froilan Torres C, Burgos García A,et al. Endoscopic management of esophageal varices[J]. World J Gastrointest Endosc, 2012, 4(7):312-322.
[10] Kim SJ, Oh SH, Jo Jm, et al. Experiences with endoscopic interventions for variceal bleeding in children with portal hypertension:a single center study[J]. Pediatr Gastroenterol Hepatol Nutr, 2013,16(4):248-253.
[11] 崔少波.聚桂醇硬化治疗食管静脉曲张的临床研究[J]. 中外医学研究, 2015,13(30):112-113.
[12] 司淑平,占强,王辉, 等. 内镜下聚桂醇注射液硬化治疗食管静脉曲张破裂出血的效果观察[J]. 中国内镜杂志, 2016,22(6):1-4.
[13] Irisawa A, Obara K, Sato Y, et al. EUS analysis of collateral veins inside and outside the esophageal wall in portal hypertension[J]. Gastrointest Endosc, 1999, 50(3):374-380.
[14] Zaman A, Chalasani N. Bleeding caused by portal hypertension[J].Gastroenterol Clin North Am, 2005, 34(4):623-642.
[15] Szczepanik A B, Dabrowski W P, Szczepanik A M, et al. Sclerotherapy of esophageal varices in severe hemophilia a patient and high titer inhibitor-case report[J]. Pol Przegl Chir, 2015, 87(9):464-468.
[16] Kong D R, Wang J G,Chen C, et al. Effect of intravariceal sclerotherapy combined with Przegl chir esophageal mucosal sclerotherapy using small-volume sclerosant for cirrhotic patients with high variceal pressure[J]. World J Gastroenterol, 2015, 21(9):2800-2806.
[17] 吴善彬, 许洪伟, 刘慧, 等. 血管内血管旁联合注射硬化剂治疗食管静脉曲张出血[J]. 山东大学学报, 2014,52(6):85-89.
[18] 闫文姬, 柴国君, 杨云生, 等. 食管静脉曲张硬化治疗后食管发生狭窄的相关因素[J]. 武警医学, 2012, 23(5):386-388.
[19] 王娟, 柴国君, 刘迎娣. 食管静脉曲张硬化治疗后溃疡的发生及相关因素分析[J]. 胃肠病学和肝病学杂志, 2008,17(12):1010-1012.
[20] 陈明锴,何千榆,丁百静,等. 比较内镜套扎与硬化剂预防肝硬化食管静脉曲张再出血:Meta分析[J]. 首都医科大学学报,2013,34(5):673-678.